PLAAT4 and cancer: Notably, TIG-3 and MRC5 normal fibroblasts treated with EF40 showed negligible reduction in cell viability (Supplementary Figures S2C, D), indicating the selective killing activity of EF40 specific to cancer cells, but not normal cells.